Powder: -20°C for 3 years | In solvent: -80°C for 1 year
TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 µM) with potential anticancer activity.TDRL-551 inhibits RPA-DNA interaction and enhances the efficacy of platinum-based chemotherapy for lung and ovarian cancer.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | In stock | $ 89.00 | |
5 mg | In stock | $ 213.00 | |
10 mg | In stock | $ 313.00 | |
25 mg | In stock | $ 663.00 | |
50 mg | In stock | $ 1,060.00 | |
100 mg | In stock | $ 1,730.00 | |
1 mL * 10 mM (in DMSO) | In stock | $ 235.00 |
Description | TDRL-551 is a novel and potent replication protein A (RPA) inhibitor (IC50=18 µM) with potential anticancer activity.TDRL-551 inhibits RPA-DNA interaction and enhances the efficacy of platinum-based chemotherapy for lung and ovarian cancer. |
Molecular Weight | 591.83 |
Formula | C25H23ClIN3O4 |
CAS No. | 1644626-43-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 60 mg/mL (101.38 mM), Sonication is recommended.
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
TDRL-551 1644626-43-6 Others TDRL 551 TDRL551 inhibitor inhibit